KUALA LUMPUR (Bernama): Sinovac Biotech Ltd, the developer of CoronaVac Covid-19 vaccine, has defended the efficacy of its two-dose vaccine including against the Delta variant.
Company spokesperson Liu Peicheng said although no data is available on its protective effect yet, studies have proven the vaccine’s efficacy in countries such as Brazil, Indonesia, Chile and Turkey where the vaccine has been widely used.
Already a subscriber? Log in.
Get 30% off with our ads free Premium Plan!
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
